THU546 A Lasofoxifene/Elacestrant Hybrid Antiestrogen Shows Effective Anti-tumoral Activities In Y537S ESR1 Breast Cancer Xenografts

Disclosure: K.S. Young: None. G.R. Hancock: None. S. Kregel: None. S.W. Fanning: Advisory Board Member; Self; Olema Oncology. Grant Recipient; Self; Olema Oncology. In the United States, breast cancer is the second leading cause of cancer related deaths among women. Over 70 percent of these breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Kristen S, Hancock, Govinda R, Kregel, Steven, Fanning, Sean William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554897/
http://dx.doi.org/10.1210/jendso/bvad114.2172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554897/
http://dx.doi.org/10.1210/jendso/bvad114.2172

Ejemplares similares